On June 28, 2022, the Tianjin Automation Factory of Agilebio Group moved to a new location and held a ribbon-cutting ceremony. Zhang Yuewei, Director of the Biomedical Department of Tianjin Science and Technology Bureau, Xu Xiangbin, Deputy Director of Tianjin Development Zone Pharmaceutical Bureau, Professor Chen Ning of Tianjin University of Science and Technology, Mr. Xu Xiangke, Vice President and Secretary of the Board of Directors of Gloria Pharmaceutical Group (Tianjin) Co., Ltd., and leaders of many enterprises, including Tianjin Pharmaceutical Group, Tianjin Alta Technology, Tianjin Quanhecheng Technology, Tianjin Hankang Pharmaceutical, Tianjin Pharmaceutical Biotechnology, BGI, and Emide Biopharmaceutical Co., Ltd. attended the ceremony. Mr. Yin Zheng, founder and chairman of Investment Management Co., Ltd., also sent a congratulatory video.
Ribbon-cutting ceremony
Guest speeches
Dr. Wang Qunjie gave a speech of thanks
Convergence of cutting-edge biological technologies – breaking through the monopoly and empowering high-end manufacturing academic salons
Taking this opportunity, Agilebio &Bioseps Purification held an academic salon on “Convergence of Cutting-edge Technologies of Biology – Breaking through Monopoly and Empowering High-end Manufacturing”.
The salon was organized by Gloria Pharmaceutical Group (Tianjin) Co., Ltd., WuXi AppTec, Tianjin Quanhecheng Technology Co., Ltd., Tianjin Alta Technology Co., Ltd., Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd., Tianjin University of Science and Technology, Shenzhen BGI Co., Ltd., Sphynx Drug R&D (Tianjin) Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Estuokang Biopharmaceutical (Tianjin) Co., Ltd., Tianjin Jiankai Technology Co., Ltd., Jiashenghua (Tianjin) Technology Co., Ltd., Bozheng Capital Investment Co., Ltd. and Agilebio Group jointly participated.
At the meeting, a number of experts published “Oligonucleotide API Production: Opportunities and Challenges”, “Restructure from silica to silica: Correlation between the structure, surface properties and industrial chromatographic separation of silica gel”, “From Chemistry to Biology – Building a Bridge in Synthetic Biology of Nucleic Acid Drugs”, “Status and Trends of Standards at Home and Abroad”, “Analysis of Impurity Control Strategy”, “High-end Amino Acid Efficient and Green Manufacturing Technology”, “Clinical Mass Spectrometry Helps Precision Medicine”, ” Cutting-edge equipment and technology – breaking through the bottleneck of biomedical “intelligent manufacturing” and other related professional reports. Focusing on the biomedical industry, we will deeply explore the current situation and innovative development of cutting-edge technologies, and provide assistance for jointly building a highland for the biomedical industry.
Celebrate the housewarming and development
Bioseps Purification has launched a special promotion of some product strength
Follow us
Complete sets of industrial chromatography purification processes and solutions
Gram to kilogram purification preparation services
Complete sets of separation and purification process equipment that meet GMP requirements
Industrial chromatography separation packings
New extraction and purification materials for laboratory and industrial production
Biomedicine, clinical testing and other sample pretreatment materials, testing kits and supporting automation systems
